- Home
- IGC vs DRK Comparison
IGC vs DRK Comparison
Compare IGC & DRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.27
Company Overview
Basic Information| Metric | IGC | DRK |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.0M | 26.9M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IGC | DRK |
|---|---|---|
| Price | $0.27 | $2.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 505.2K | 249.6K |
| Earning Date | 03-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,271,000.00 | ★ $11,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $2.70 |
| 52 Week High | $0.45 | $3.12 |
Technical Indicators
Market Signals| Indicator | IGC | DRK |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 50.00 |
| Support Level | $0.27 | $2.70 |
| Resistance Level | $0.31 | N/A |
| Average True Range (ATR) | 0.01 | 0.23 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 64.85 | 57.14 |
Price Performance
Historical Comparison IGC
DRK
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.